Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > TO THE MOON again. TIME TO DUMP. It's definitely done now.

<< Previous

Bullboard Posts

Next >>

Post by losingmyshirton Oct 06, 2021 11:48am

162 Views

Post# 33973613

TO THE MOON again. TIME TO DUMP. It's definitely done now.

Bob is scrambling to get his internet back but Burger King is holding hard.
the terms are simple. Buy a burger and fries and get free wi-fi. They are deadlocked.
Bob is offering to give Burger King shares of his non existant motherlode but Burger King will not bite.

Until Bob can get his free wi-fi back there will be no news.

GO KALYTERA .

oh..new all time low was the signal to sell and run. Have a wonderful day.

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals